“Prednisone inhibits osteosarcoma cell by regulating the Wnt/β-catenin signaling pathway”, Bangladesh J Pharmacol, vol. 19, no. 3, pp. 73–80, Dec. 2024, doi: 10.3329/bjp.v19i3.76379.